前沿生物 (688221.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(前沿生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
关 闭
完整财报对比
2020年三季报2020年中报2019年年报2019年三季报2019年一季报2018年年报
上市前/上市后 上市前上市前上市前上市前上市前上市前
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 23,224,479.406,847,374.2520,860,022.6310,977,440.202,275,301.691,911,053.82
 营业收入(元) 23,224,479.406,847,374.2520,860,022.6310,977,440.202,275,301.691,911,053.82
二、营业总成本(元) 192,078,832.24110,832,668.44199,498,582.29146,307,251.9547,120,318.21262,777,691.24
 营业成本(元) 22,864,004.4011,891,907.6031,262,946.8721,359,002.366,611,871.6811,988,452.66
 研发费用(元) 100,271,612.4556,309,263.7085,421,236.8365,462,221.6920,122,254.4087,052,060.16
 营业税金及附加(元) 1,070,615.97715,761.29944,524.87554,985.3739,875.60145,489.65
 销售费用(元) 20,569,589.9011,611,814.6820,054,290.8115,476,238.154,376,706.328,114,460.17
 管理费用(元) 46,303,592.2631,254,239.2766,581,597.0149,611,504.4514,603,886.41156,155,300.59
 财务费用(元) 999,417.26-950,318.10-4,766,014.10-6,156,700.071,341,776.70-678,071.99
  其中:利息费用(元) 1,337,990.26898,924.42899,117.95441,032.1877,637.07135,112.19
  其中:利息收入(元) 1,312,933.961,062,538.463,850,967.263,119,564.261,081,206.981,080,193.89
三、其他经营收益
 加:公允价值变动收益(元) 220,801.15-11,479.44312,723.281,079,242.47929,959.33-
 加:投资收益(元) 3,277,639.652,472,755.987,682,438.595,247,685.12982,153.6611,248,411.91
 资产处置收益(元) ------18,346.81
 资产减值损失(元) ----1,449.55-
 信用减值损失(元) ----22,497.55-
 其他收益(元) 2,737,839.462,079,945.473,507,062.231,953,384.44651,128.151,899,749.78
四、营业利润(元) -166,750,854.11-103,487,435.48-193,494,611.83-134,569,031.85-42,281,775.38-247,726,701.69
 加:营业外收入(元) 170,000.0050,000.0020,000.00--502,000.00
 减:营业外支出(元) 26,516.385,115.691,633,345.36161,594.36-21,411.77
五、利润总额(元) -166,607,370.49-103,442,551.17-195,107,957.19-134,730,626.21-42,281,775.38-247,246,113.46
六、净利润(元) -166,607,370.49-103,442,551.17-195,107,957.19-134,730,626.21-42,281,775.38-247,246,113.46
(一)按经营持续性分类
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -163,664,824.09-101,935,663.07-192,449,750.97-133,031,837.92-41,834,228.66-247,065,185.46
  少数股东损益(元) -2,942,546.40-1,506,888.10-2,658,206.22-1,698,788.29-447,546.72-180,928.00
 扣除非经常性损益后的净利润(元) -170,044,600.00-106,521,800.00-202,338,600.00-141,150,600.00-44,397,500.00-167,355,300.00
七、每股收益
 一、基本每股收益(元) -0.61-0.38-0.73-0.51-0.17-1.02
 二、稀释每股收益(元) -0.61-0.38-0.73-0.51-0.17-1.02
八、其他综合收益(元) -13,943.8215,384.2111,406.6116,818.141,148.30-2,981,637.00
 归属于母公司股东的其他综合收益(元) -13,943.8215,384.2111,406.6116,818.141,148.30-2,981,637.00
九、综合收益总额(元) -166,621,314.31-103,427,166.96-195,096,550.58-134,713,808.07-42,280,627.08-250,227,750.46
 归属于母公司所有者的综合收益总额(元) -163,678,767.91-101,920,278.86-192,438,344.36-133,015,019.78-41,833,080.36-250,046,822.46
 归属于少数股东的综合收益总额(元) -2,942,546.40-1,506,888.10-2,658,206.22-1,698,788.29-447,546.72-180,928.00
公告日期 2020-10-272020-09-302020-05-272020-10-272019-08-132019-08-13
审计意见(境内) 标准无保留意见标准无保留意见标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院